Harte Hanks Balance Sheet Health
Financial Health criteria checks 4/6
Harte Hanks has a total shareholder equity of $21.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $108.1M and $87.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$5.94m |
Equity | US$21.05m |
Total liabilities | US$87.08m |
Total assets | US$108.13m |
Recent financial health updates
Recent updates
Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues
Jul 03With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case
Nov 03Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price
Oct 13Harte Hanks (NASDAQ:HHS) Is Experiencing Growth In Returns On Capital
Jun 08Should You Investigate Harte Hanks, Inc. (NASDAQ:HHS) At US$8.83?
Mar 16Does Harte Hanks (NASDAQ:HHS) Deserve A Spot On Your Watchlist?
Feb 22Are Investors Undervaluing Harte Hanks, Inc. (NASDAQ:HHS) By 22%?
Dec 07If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity
Oct 27Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)
Sep 27Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger
Sep 19Harte Hanks and FEVO announce expanding partnership
Sep 15Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors
Aug 23Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market
Aug 13Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M
Aug 11What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?
Jul 26Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential
Jul 14Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock
May 23Financial Position Analysis
Short Term Liabilities: HHS's short term assets ($53.8M) exceed its short term liabilities ($36.9M).
Long Term Liabilities: HHS's short term assets ($53.8M) exceed its long term liabilities ($50.1M).
Debt to Equity History and Analysis
Debt Level: HHS is debt free.
Reducing Debt: HHS currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if HHS has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HHS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/23 06:41 |
End of Day Share Price | 2025/01/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Harte Hanks, Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Daniel Leben | Baird |
Edward Atorino | Benchmark Company |
Daniel Salmon | BMO Capital Markets Equity Research |